Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TSS, Inc. | 150,000 | reported | 06 Jun 2012 | tx 13+498,410−48,405 |
| BROADWING CORP | 35,096 | reported | 03 Apr 2006 | tx 4+140,000−17,892 |
| SUPERNUS PHARMACEUTICALS, INC. | 9,682 | reported | 06 Mar 2026 | tx 73+366,725−62,362 |
| OPGEN INC | 1,509 | reported | 17 May 2021 | tx 30+982,830−27,078 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 1,450 | 54.73 USD | |
| 06 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | |
| 06 Mar 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 1,433 | 54.73 USD | |
| 06 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | |
| 06 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | deriv |
| 06 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | deriv |
| 28 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | deriv |
| 28 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | deriv |
| 25 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 2,500 | 0.00 USD | |
| 25 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 1,279 | 50.69 USD | |
| 25 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 2,500 | 0.00 USD | deriv |
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 500 | 0.00 USD | |
| 24 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 1,524 | 50.86 USD | |
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | |
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1,125 | 0.00 USD | |
| 24 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 603 | 51.35 USD | |
| 24 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 242 | 50.86 USD | |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1,125 | 0.00 USD | deriv |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | deriv |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 500 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 17,500 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | 0.00 USD | deriv |
| 22 Aug 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 11,780 | 44.49 USD | |
| 10 Mar 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 1,062 | 32.06 USD | |
| 10 Mar 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 955 | 32.06 USD |
2 purchases reported after at least 12 months of silence — most recent on 18 Jul 2017.